The global sterility testing market size reached US$ 936 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,732.8 Million by 2028, exhibiting a growth rate (CAGR) of 10.30% during 2023-2028. The significant growth in the pharmaceutical industry, the growing testing demand in the manufacturing of medical devices, and the recent development rapid microbial detection systems represent some of the key factors driving the market.
Sterility testing refers to the process of determining the presence or absence of microorganisms and harmful pathogens on a product or in a sample. It includes membrane filtration, direct inoculation, immersion method, and molecular techniques, such as polymerase chain reaction (PCR). Sterility testing is widely used for quality control, manufacturing process, regulatory compliance, product stability, device safety, scientific research, and environmental monitoring. It provides faster, more accurate, and reliable testing results, which enhances patient safety, allows early detection, prevents outbreaks, and minimizes the risk of infections and other diseases. It also aids companies in improving process efficiency, increasing productivity, preventing product recalls, and identifying sources of contamination. As a result, sterility testing finds extensive applications across the pharmaceutical, biotechnology, and healthcare industries.
Sterility Testing Market Trends:
The significant growth in the pharmaceutical industry is one of the primary factors creating a positive outlook for the market. Sterility testing is widely used in the pharmaceutical and biopharmaceutical manufacturing processes to ensure the safety and efficacy of drugs, capsules, tablets, vaccines, injectables, insulin, eye drops, ointments, creams, gels, aerosols, powders, and nebulizers. In addition to this, the widespread testing utilization in the development of new pharmaceuticals, such as personalized medicines and gene therapy, is acting as another growth-inducing factor. Furthermore, the growing testing demand in the manufacturing of various medical devices, such as scalpels, forceps, surgical scissors, catheters, contact lenses, infusion pumps, pacemakers, artificial joints, bone grafts, and other implants, is providing an impetus to the market growth. Additionally, the recent development of rapid microbial detection systems that use polymerase chain reaction (PCR) and next-generation sequencing (NGS) to detect contamination quickly and accurately in a variety of samples and products is positively influencing the market growth. Besides this, the introduction of robotics and automation technology to handle large volumes of samples, reduce human errors, and improve the efficiency of the testing process is providing a considerable boost to the market growth. Moreover, the emerging trend of outsourcing sterility testing, which allows companies to reduce costs and focus on core competencies, is propelling the market growth. Other factors, including rising concerns among the masses regarding healthcare-associated infections (HAI), extensive research and development (R&D) activities, and the growing testing demand in the biotechnology industry, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global sterility testing market, along with forecasts at the global, regional, and country levels from 2023-2028 Our report has categorized the market based on product and service, test type, application, and end user.
Product and Service Insights:
- Kits and Reagents
The report has provided a detailed breakup and analysis of the sterility testing market based on the product and service. This includes instruments, kits and reagents, and services. According to the report, kits and reagents represented the largest segment.
Test Type Insights:
- Membrane Filtration
- Direct Inoculation
A detailed breakup and analysis of the sterility testing market based on the test type has also been provided in the report. This includes membrane filtration, direct inoculation, and others. According to the report, membrane filtration accounted for the largest market share.
- Pharmaceutical and Biological Manufacturing
- Medical Device Manufacturing
A detailed breakup and analysis of the sterility testing market based on the application has also been provided in the report. This includes pharmaceutical and biological manufacturing, medical device manufacturing, and others. According to the report, pharmaceutical and biological manufacturing accounted for the largest market share.
End User Insights:
- Pharmaceutical Companies
- Biotechnology Companies
A detailed breakup and analysis of the sterility testing market based on the end user has also been provided in the report. This includes pharmaceutical companies, biotechnology companies, and others. According to the report, pharmaceutical companies accounted for the largest market share.
- North America
- United Kingdom
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for sterility testing. Some of the factors driving the North America sterility testing market included rising health concerns, increasing emphasis on quality control, and rapid technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global sterility testing market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include bioMérieux SA, Charles River Laboratories International Inc., Merck KGaA, Rapid Micro Biosystems Inc., Sartorius AG, SGS S.A., Sotera Health Company, Steris Corporation, Thermo Fisher Scientific Inc., WuXi AppTec, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
|Base Year of the Analysis
|Product and Services Covered
||Instruments, Kits and Reagents, Services
|Test Types Covered
||Membrane Filtration, Direct Inoculation, Others
||Pharmaceutical and Biological Manufacturing, Medical Device Manufacturing, Others
|End Users Covered
||Pharmaceutical Companies, Biotechnology Companies, Others
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||bioMérieux SA, Charles River Laboratories International Inc., Merck KGaA, Rapid Micro Biosystems Inc., Sartorius AG, SGS S.A., Sotera Health Company, Steris Corporation, Thermo Fisher Scientific Inc., WuXi AppTec, etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the sterility testing market from 2017-2028.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global sterility testing market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the sterility testing industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.